[Experimental animal studies on the anti-inflammatory effect of pyridinolcarbamate].
D000818:Animals; D001011:Aorta / Q000378:metabolism; D002219:Carbamates / Q000494:pharmacology*; D003238:Connective Tissue / Q000187:drug effects / Q000378:metabolism*; D003864:Depression, Chemical; D003911:Dextrans; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004731:Endotoxins; D006025:Glycosaminoglycans / Q000378:metabolism; D006097:Granulation Tissue / Q000378:metabolism; D007271:Injections, Intradermal; D007274:Injections, Intraperitoneal; D008297:Male; D009929:Organ Size; D011727:Pyridinolcarbamate / Q000378:metabolism / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012790:Shwartzman Phenomenon / Q000378:metabolism; D013210:Staphylococcus; D013462:Sulfur Radioisotopes; D013464:Sulfuric Acids / Q000378:metabolism; D013997:Time Factors
D002219:Carbamates; D003911:Dextrans; D004731:Endotoxins; D006025:Glycosaminoglycans; D013462:Sulfur Radioisotopes; D013464:Sulfuric Acids; D011727:Pyridinolcarbamate
Tierexperimentelle Untersuchungen über die antientzündliche Wirkung von Pyridinolcarbamat